Cargando…
Infusional high-density lipoproteins therapies as a novel strategy for treating atherosclerosis
High-density lipoproteins (HDL) have received considerable interest as a target for the development of novel anti-atherosclerotic agents beyond conventional approaches to lipid lowering. While a number of approaches have focused on modifying remodeling and expression pathways implicated in the regul...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Termedia Publishing House
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206363/ https://www.ncbi.nlm.nih.gov/pubmed/28144273 http://dx.doi.org/10.5114/aoms.2016.60941 |